474 related articles for article (PubMed ID: 11684952)
1. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study.
Cook JR; Dehner LP; Collins MH; Ma Z; Morris SW; Coffin CM; Hill DA
Am J Surg Pathol; 2001 Nov; 25(11):1364-71. PubMed ID: 11684952
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
Qiu X; Montgomery E; Sun B
Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.
Coffin CM; Hornick JL; Fletcher CD
Am J Surg Pathol; 2007 Apr; 31(4):509-20. PubMed ID: 17414097
[TBL] [Abstract][Full Text] [Related]
4. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases.
Li XQ; Hisaoka M; Shi DR; Zhu XZ; Hashimoto H
Hum Pathol; 2004 Jun; 35(6):711-21. PubMed ID: 15188137
[TBL] [Abstract][Full Text] [Related]
5. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases.
Cessna MH; Zhou H; Sanger WG; Perkins SL; Tripp S; Pickering D; Daines C; Coffin CM
Mod Pathol; 2002 Sep; 15(9):931-8. PubMed ID: 12218210
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.
Rabban JT; Zaloudek CJ; Shekitka KM; Tavassoli FA
Am J Surg Pathol; 2005 Oct; 29(10):1348-55. PubMed ID: 16160478
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.
Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H
Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.
Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R
Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of anaplastic lymphoma kinase expression in deep soft tissue calcifying fibrous pseudotumor: evidence of a late sclerosing stage of inflammatory myofibroblastic tumor?
Sigel JE; Smith TA; Reith JD; Goldblum JR
Ann Diagn Pathol; 2001 Feb; 5(1):10-4. PubMed ID: 11172201
[TBL] [Abstract][Full Text] [Related]
11. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.
Ma Z; Hill DA; Collins MH; Morris SW; Sumegi J; Zhou M; Zuppan C; Bridge JA
Genes Chromosomes Cancer; 2003 May; 37(1):98-105. PubMed ID: 12661011
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic lymphoma kinase expression in inflammatory pseudotumors.
Chan JK; Cheuk W; Shimizu M
Am J Surg Pathol; 2001 Jun; 25(6):761-8. PubMed ID: 11395553
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory pseudotumor of lymph node and spleen: an entity biologically distinct from inflammatory myofibroblastic tumor.
Kutok JL; Pinkus GS; Dorfman DM; Fletcher CD
Hum Pathol; 2001 Dec; 32(12):1382-7. PubMed ID: 11774173
[TBL] [Abstract][Full Text] [Related]
14. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory myofibroblastic tumor in children: clinical review with anaplastic lymphoma kinase, Epstein-Barr virus, and human herpesvirus 8 detection analysis.
Mergan F; Jaubert F; Sauvat F; Hartmann O; Lortat-Jacob S; Révillon Y; Nihoul-Fékété C; Sarnacki S
J Pediatr Surg; 2005 Oct; 40(10):1581-6. PubMed ID: 16226988
[TBL] [Abstract][Full Text] [Related]
16. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.
Lawrence B; Perez-Atayde A; Hibbard MK; Rubin BP; Dal Cin P; Pinkus JL; Pinkus GS; Xiao S; Yi ES; Fletcher CD; Fletcher JA
Am J Pathol; 2000 Aug; 157(2):377-84. PubMed ID: 10934142
[TBL] [Abstract][Full Text] [Related]
17. Assessment of ALK Fusions in Uncommon Inflammatory Myofibroblastic Tumors With ALK IHC Positivity but FISH-Equivocal Findings by Targeted RNA Sequencing.
Yao Q; Bai Q; Zhang X; Ji G; Chang H; Cai X; Yu L; Wang J; Zhu X; Zhou X
Arch Pathol Lab Med; 2022 Oct; 146(10):1234-1242. PubMed ID: 35041745
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.
Cools J; Wlodarska I; Somers R; Mentens N; Pedeutour F; Maes B; De Wolf-Peeters C; Pauwels P; Hagemeijer A; Marynen P
Genes Chromosomes Cancer; 2002 Aug; 34(4):354-62. PubMed ID: 12112524
[TBL] [Abstract][Full Text] [Related]
19. Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors.
Hornick JL; Sholl LM; Dal Cin P; Childress MA; Lovly CM
Mod Pathol; 2015 May; 28(5):732-9. PubMed ID: 25612511
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification.
Takeuchi K; Soda M; Togashi Y; Sugawara E; Hatano S; Asaka R; Okumura S; Nakagawa K; Mano H; Ishikawa Y
Clin Cancer Res; 2011 May; 17(10):3341-8. PubMed ID: 21430068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
